500,910 Shares in CVS Health Corporation $CVS Bought by Freestone Grove Partners LP

Freestone Grove Partners LP bought a new stake in shares of CVS Health Corporation (NYSE:CVS) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 500,910 shares of the pharmacy operator’s stock, valued at approximately $51,819,000.

Several other institutional investors have also added to or reduced their stakes in the business. Caisse de depot et placement du Quebec purchased a new stake in CVS Health during the 2nd quarter worth approximately $81,368,000. Gallagher Fiduciary Advisors LLC purchased a new position in shares of CVS Health in the second quarter worth $672,000. First Bancorp Inc ME purchased a new position in shares of CVS Health in the second quarter worth $322,000. Jupiter Topco LLC acquired a new stake in shares of CVS Health during the second quarter worth $380,460,000. Finally, EFG International AG purchased a new stake in shares of CVS Health during the second quarter valued at $188,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of CVS stock opened at $94.22 on Thursday. The stock has a market cap of $120.50 billion, a PE ratio of 24.93, a price-to-earnings-growth ratio of 0.84 and a beta of 0.61. The business has a 50-day simple moving average of $101.63 and a 200-day simple moving average of $89.33. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a 52-week low of $69.51 and a 52-week high of $110.68.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, topping the consensus estimate of $1.87 by $0.71. The firm had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.CVS Health’s revenue for the quarter was up 7.3% compared to the same quarter last year. During the same period last year, the company earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, equities analysts expect that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were paid a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.8%. CVS Health’s dividend payout ratio (DPR) is presently 70.37%.

Wall Street Analyst Weigh In

CVS has been the subject of a number of research analyst reports. DA Davidson raised their target price on CVS Health from $80.00 to $100.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. HSBC reissued a “hold” rating and issued a $103.00 price objective on shares of CVS Health in a report on Monday, July 6th. Truist Financial lifted their target price on CVS Health from $108.00 to $118.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Royal Bank Of Canada increased their price target on shares of CVS Health from $107.00 to $113.00 and gave the stock an “outperform” rating in a report on Thursday, July 9th. Finally, UBS Group raised their price target on shares of CVS Health from $122.00 to $126.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Twenty-two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, CVS Health has an average rating of “Moderate Buy” and a consensus price target of $107.17.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.